Redpoint Bio Corporation (OTC BB: RPBC), a leading biotechnology company, is focused on developing better tasting products for the pharmaceutical, food and beverage industries. The recent progression in taste biology has produced a number of new approaches to the discovery and development of innovative taste blockers and enhancers. The company leverages its modern tools of biotechnology to discover revolutionary ways to make medicines more palatable and enhance the taste of prepared foods and beverages. For further information, visit the Company’s web site at www.redpointbio.com.
- 17 years ago
QualityStocks
Redpoint Bio Corporation (OTC BB: RPBC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Receives Court Approval for Shareholder Claim Settlement
Vision Marine Technologies (NASDAQ: VMAR) announced that on Aug. 13, 2025, the New York State…
-
QualityStocksNewsBreaks – GlobalTech Corporation (OTCID: GTLK) Posts 23% Revenue Growth in Q2 2025 on Strong Telecom Performance
GlobalTech (OTCID: GTLK), a technology holding company specializing in artificial intelligence and big data solutions,…
-
QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Narrows Q2 Loss 66% as E-Commerce Growth Offsets Healthcare Headwinds
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company in healthcare and technology,…